4.12. Analysis.
Comparison 4 Flecainide versus placebo or no treatment, Outcome 12 Atrial fibrillation recurrence – sensitivity analysis: low risk of bias studies.
Comparison 4 Flecainide versus placebo or no treatment, Outcome 12 Atrial fibrillation recurrence – sensitivity analysis: low risk of bias studies.